Request Clinical Starter Kits for Your Patients Today! Request Now

 Resveratrol STUDIES

ResVida® resveratrol is readily bioavailable and exerts positive effects on endothelial function, study shows

Highlights Randomized, double-blind, controlled, cross-over with 20 adults with hypertension Supplementation consisted of single doses of resVida® (30, 90 and 270 mg) All amounts of resVida® significantly improve endothelial function...
on February 25, 2020

Resveratrol supplementation reduces key inflammatory biomarkers, meta-analysis shows

Highlights Meta-analysis of 17 randomized, controlled trials (736 participants) Resveratrol supplementation significantly reduces TNF-alpha and C-reactive protein Median dosage is 300 mg/day for 2 months   Summary This meta-analysis was performed...
on February 25, 2020

Resveratrol significantly improves glycemic control in people with diabetes, meta-analysis shows

Highlights Meta-analysis with 11 randomized, controlled clinical trials comprising 388 subjects In people with diabetes, resveratrol significantly improves glucose control and insulin sensitivity. Median intake is 100 mg/day for 12...
on February 25, 2020

Resveratrol improves disease activity and quality of life in people with ulcerative colitis, study shows

Highlights Randomized, double-blind, placebo-controlled trial with 56 adults with mild-to-moderate ulcerative colitis Supplementation consists of trans-resveratrol (500 mg/day) for 6 weeks Resveratrol significantly increases body’s antioxidant status, reduces disease activity and improves...
on February 25, 2020

Resveratrol exerts beneficial effects on cerebral blood flow in healthy adults, study shows

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 22 healthy adults Supplementation consists of single doses of 99% pure trans-resveratrol (250 mg or 500 mg) Resveratrol increases cerebral blood flow during cognitive performance, compared to...
on February 25, 2020